Upgrading GBM Translational Models for Accelerated Therapeutic Advances
Time: 11:00 am
day: Pre-Conference Workshop Day New
Details:
Optimization of patient-derived models, innovations in translational platforms, and strategies to bridge the translational gap.
This workshop will gather experts to discuss:
- Optimizing patient-derived models for personalized glioblastoma therapies
- Implementing PDX and organoid models for more effective drug screening and enhancing treatment response prediction with in vitro and in vivo models
- GBM translational models: Beyond the traditional
- Exploring advanced 3D and ex vivo culture systems for glioblastoma research, harnessing organ-on-a-chip and microfluidic platforms for high-throughput screening and utilizing patient-derived organoids for modelling tumor heterogeneity and drug resistance
- Review case studies highlighting successful translation of preclinical findings to clinical trials
